The combustion-engine ban was hailed as a major win in climate fight when adopted in 2023. But carmakers and their backers have lobbied hard over the past year for Brussels to relax it, in the face of fierce competition from China and a slower-than-expected shift to electric vehicles (EVs).
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each. This transaction highlights investor interest in the agrochemical firm. Mahamaya Lifesciences manufactures pesticide formulations and crop protection products. The company has shown strong financial growth recently. Its shares have performed well since their market debut.
ICICI Prudential AMCs Rs 10,600 crore IPO drew nearly Rs 3 lakh crore in bids, led by strong global and domestic institutional demand. Robust anchor participation underscored confidence, though valuation and OFS structure suggest a steady, not explosive, listing.
